Bioelectronics Corp (BIEL)

[art2426]

I would have to think that anyone that has followed this company and is aware of the considerable amount of outstanding shares would be smart enough to know that a reverse stock split is a serious probability and is already factored into this very low price of double and previously triple zeros. In fact I feel that, as most often happens, the market is overreacting to the outstanding shares/inevitable reverse split and with a market cap of $14 million (10 bil(?) outstanding x .0014), I am perceiving this as oversold and am adding to my position. This of course is assuming the successful path to FDA submission and acceptance. With the FDA seemingly now educated and informed on PEMF and its safety AND benefits for pain relief resulting in this "new" category to place such devices, I am assuming a major POP in the stock price as more positive FDA news is revealed on this subject and its newly "accepted" science.